SGHT (Sight Sciences) Float Percentage Of Total Shares Outstanding: 72.50% (As of Jun. 29, 2026)


SGHT Sight Sciences Inc SGHT
71 GF Score
Price $5.84
GF Value $4.49
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Sight Sciences Float Percentage Of Total Shares Outstanding?

Sight Sciences SGHT +3.00% 71 Float Percentage Of Total Shares Outstanding is 72.50% as of Jun. 29, 2026. GuruFocus rates SGHT with a GF Score™ of 71/100 and a GF Value™ of $4.49 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sight Sciences's float shares is 39.45 Mil. Sight Sciences's total shares outstanding is 54.41 Mil. Sight Sciences's float percentage of total shares outstanding is 72.50%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sight Sciences's Insider Ownership is 24.81%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sight Sciences's Institutional Ownership is 44.98%.

SGHT
71GF Score
Sight Sciences Inc SGHT
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sight Sciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sight Sciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=39.45/54.41
=72.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 72.50% mean?
Sight Sciences (SGHT) has a Float Percentage Of Total Shares Outstanding of 72.50% as of Jun. 29, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sight Sciences and its competitors.
Is Sight Sciences' Float Percentage Of Total Shares Outstanding too high?
Sight Sciences' current Float Percentage Of Total Shares Outstanding is 72.50%. Overall, Sight Sciences has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sight Sciences' Float Percentage Of Total Shares Outstanding compare to SENS and LAB?
Sight Sciences' Float Percentage Of Total Shares Outstanding of 72.50% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sight Sciences and its competitors. Sight Sciences's current Float Percentage Of Total Shares Outstanding is 72.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sight Sciences stock overvalued right now?
Based on GuruFocus' analysis, Sight Sciences (SGHT) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.49, compared to a current price of $5.84 — trading 30.1% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 72.50%. Sight Sciences' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sight Sciences (SGHT), the current Float Percentage Of Total Shares Outstanding is 72.50% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sight Sciences (SGHT) Overvalued in 2026?

Based on GuruFocus' analysis, Sight Sciences stock appears to be overvalued. The current stock price of $5.84 is trading 30.1% above its estimated GF Value™ of $4.49. GuruFocus considers Sight Sciences to be Modestly Overvalued.

Key valuation signals for SGHT:

  • Float Percentage Of Total Shares Outstanding: 72.50%
  • GF Value™: $4.49 vs. price of $5.84 (30.1% above fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the SGHT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sight Sciences Business Description

Address 4040 Campbell Avenue, Suite 100, Menlo Park, CA, USA, 94025
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
71GF Score

Get the complete analysis for SGHT

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.84
Price
$4.49
GF Value